Radiotherapy Market Size

Radiotherapy Market Size

Radiotherapy Market size was valued at around USD 7 billion in 2023 and is estimated to grow at 5.7% CAGR from 2024 to 2032. Radiotherapy is a medical treatment that uses high doses of radiation to kill cancer cells and shrink tumors.

The radiation, often in the form of X-rays, gamma rays, or charged particles, targets and damages the DNA within cancer cells, preventing them from growing and dividing. This treatment can be delivered externally using a machine called a linear accelerator (external beam radiotherapy) or internally by placing radioactive material inside the body near cancer cells (brachytherapy).
 

Technological advancements have markedly enhanced the precision and efficacy of radiotherapy, enabling targeted treatments that reduce harm to nearby healthy tissues. With cancer rates rising worldwide, the need for sophisticated treatments has surged, spurring investments in cutting-edge radiotherapy solutions. For instance, the global cancer burden is expected to increase significantly about 60% by 2040, with tobacco being the leading preventable cause of cancer. With 18.1 new million cases in 2018, 29.4 million cases can be expected by 2040 due to the aging and growing population, according to the third edition of the Cancer Atlas. Additionally, as awareness grows about the advantages of early cancer diagnosis and treatment, radiotherapy adoption rates are climbing. Complementing this trend, government backing and investments in cancer research and treatment infrastructure are bolstering the radiotherapy sector.
 

Furthermore, enhancing the precision of radiation therapy is crucial to target tumors accurately while minimizing harm to surrounding tissues. Image-guided radiotherapy, a product of extensive research, leverages advanced imaging methods to enhance tumor visualization. The ongoing enhancements in tumor imaging, specifically for radiotherapy, are poised to be the primary growth catalyst for this market in the next decade.